242 related articles for article (PubMed ID: 12180540)
1. Long-circulating poly(ethylene glycol)-modified gelatin nanoparticles for intracellular delivery.
Kaul G; Amiji M
Pharm Res; 2002 Jul; 19(7):1061-7. PubMed ID: 12180540
[TBL] [Abstract][Full Text] [Related]
2. Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive biodegradable system for paclitaxel delivery.
Potineni A; Lynn DM; Langer R; Amiji MM
J Control Release; 2003 Jan; 86(2-3):223-34. PubMed ID: 12526819
[TBL] [Abstract][Full Text] [Related]
3. Biodistribution and targeting potential of poly(ethylene glycol)-modified gelatin nanoparticles in subcutaneous murine tumor model.
Kaul G; Amiji M
J Drug Target; 2004; 12(9-10):585-91. PubMed ID: 15621684
[TBL] [Abstract][Full Text] [Related]
4. Cellular interactions and in vitro DNA transfection studies with poly(ethylene glycol)-modified gelatin nanoparticles.
Kaul G; Amiji M
J Pharm Sci; 2005 Jan; 94(1):184-98. PubMed ID: 15761942
[TBL] [Abstract][Full Text] [Related]
5. Tumor-targeted gene delivery using poly(ethylene glycol)-modified gelatin nanoparticles: in vitro and in vivo studies.
Kaul G; Amiji M
Pharm Res; 2005 Jun; 22(6):951-61. PubMed ID: 15948039
[TBL] [Abstract][Full Text] [Related]
6. Poly(ethylene glycol)-modified thiolated gelatin nanoparticles for glutathione-responsive intracellular DNA delivery.
Kommareddy S; Amiji M
Nanomedicine; 2007 Mar; 3(1):32-42. PubMed ID: 17379167
[TBL] [Abstract][Full Text] [Related]
7. Biodistribution and pharmacokinetic analysis of long-circulating thiolated gelatin nanoparticles following systemic administration in breast cancer-bearing mice.
Kommareddy S; Amiji M
J Pharm Sci; 2007 Feb; 96(2):397-407. PubMed ID: 17075865
[TBL] [Abstract][Full Text] [Related]
8. Long-circulating poly(ethylene glycol)-grafted gelatin nanoparticles customized for intracellular delivery of noscapine: preparation, in-vitro characterization, structure elucidation, pharmacokinetics, and cytotoxicity analyses.
Madan J; Dhiman N; Sardana S; Aneja R; Chandra R; Katyal A
Anticancer Drugs; 2011 Jul; 22(6):543-55. PubMed ID: 21471809
[TBL] [Abstract][Full Text] [Related]
9. Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs. 1. In vitro evaluations.
Shenoy D; Little S; Langer R; Amiji M
Mol Pharm; 2005; 2(5):357-66. PubMed ID: 16196488
[TBL] [Abstract][Full Text] [Related]
10. Matrix-loaded biodegradable gelatin nanoparticles as new approach to improve drug loading and delivery.
Ofokansi K; Winter G; Fricker G; Coester C
Eur J Pharm Biopharm; 2010 Sep; 76(1):1-9. PubMed ID: 20420904
[TBL] [Abstract][Full Text] [Related]
11. Poly(ethylene glycol)-block-poly(ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery.
He X; Li L; Su H; Zhou D; Song H; Wang L; Jiang X
Int J Nanomedicine; 2015; 10():1791-804. PubMed ID: 25784805
[TBL] [Abstract][Full Text] [Related]
12. Hyaluronidase enzyme core-5-fluorouracil-loaded chitosan-PEG-gelatin polymer nanocomposites as targeted and controlled drug delivery vehicles.
Rajan M; Raj V; Al-Arfaj AA; Murugan AM
Int J Pharm; 2013 Sep; 453(2):514-22. PubMed ID: 23796828
[TBL] [Abstract][Full Text] [Related]
13. Biodegradable poly(epsilon -caprolactone) nanoparticles for tumor-targeted delivery of tamoxifen.
Chawla JS; Amiji MM
Int J Pharm; 2002 Dec; 249(1-2):127-38. PubMed ID: 12433441
[TBL] [Abstract][Full Text] [Related]
14. Characterization of rhodamine loaded PEG-g-PLA nanoparticles (NPs): effect of poly(ethylene glycol) grafting density.
Essa S; Rabanel JM; Hildgen P
Int J Pharm; 2011 Jun; 411(1-2):178-87. PubMed ID: 21458551
[TBL] [Abstract][Full Text] [Related]
15. Poly(ethylene oxide)-modified poly(epsilon-caprolactone) nanoparticles for targeted delivery of tamoxifen in breast cancer.
Shenoy DB; Amiji MM
Int J Pharm; 2005 Apr; 293(1-2):261-70. PubMed ID: 15778064
[TBL] [Abstract][Full Text] [Related]
16. Intracellular delivery of saquinavir in biodegradable polymeric nanoparticles for HIV/AIDS.
Shah LK; Amiji MM
Pharm Res; 2006 Nov; 23(11):2638-45. PubMed ID: 16969696
[TBL] [Abstract][Full Text] [Related]
17. Redox and pH dual responsive poly(amidoamine) dendrimer-poly(ethylene glycol) conjugates for intracellular delivery of doxorubicin.
Hu W; Qiu L; Cheng L; Hu Q; Liu Y; Hu Z; Chen D; Cheng L
Acta Biomater; 2016 May; 36():241-53. PubMed ID: 26995505
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and physical characterization of poly(ethylene glycol)-gelatin conjugates.
Kushibiki T; Matsuoka H; Tabata Y
Biomacromolecules; 2004; 5(1):202-8. PubMed ID: 14715027
[TBL] [Abstract][Full Text] [Related]
19. [Research on Tat peptide-polyethylene glycol modified gelatin-siloxane nanoparticles across the blood-brain barrier].
Tian X; Wei F; Lin X; Feng W; Wang P
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2012 Jun; 29(3):486-90, 500. PubMed ID: 22826945
[TBL] [Abstract][Full Text] [Related]
20. Peptide-conjugated biodegradable nanoparticles as a carrier to target paclitaxel to tumor neovasculature.
Yu DH; Lu Q; Xie J; Fang C; Chen HZ
Biomaterials; 2010 Mar; 31(8):2278-92. PubMed ID: 20053444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
